Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

Development and preclinical evaluation of novel subtype-specific HDAC inhibitors for epigenetic therapy of primary brain tumors

Diese Stellenanzeige ist abgelaufen. Finden Sie hier zahlreiche ähnliche Jobs.

The Düsseldorf School of Oncology (DSO) of the University Cancer Center at
Heinrich Heine University Düsseldorf offers a
PhD Scholarship
for the collaborative PhD project
 
Development and preclinical evaluation of novel subtype-specific HDAC inhibitors for epigenetic therapy of primary brain tumors
 
within the research focus “Epigenetics and non-coding-RNA in cancer gene regulation” of the Düsseldorf School of Oncology (DSO). The DSO invites applications for this PhD scholarship within the Graduate Training Program in Oncology at the University Cancer Center of the University Hospital Düsseldorf. The project will be coordinated by the Department of Pharmaceutical and Medicinal Chemistry (WE Pharmacy) (Prof. Dr. Kurz) and Department of Neuropathology (PD Dr. Felsberg) at Heinrich-Heine-University Düsseldorf.

The DSO (http://www.hhu.de/dso/) is a research training program in which basic and clinical scientists from Heinrich Heine University Düsseldorf and University Cancer Center work together in multidisciplinary oncological research projects. The primary research goals of the DSO groups are to unravel important pathomechanisms involved in major cancer diseases and to translate these findings into better diagnostic tools and more effective therapies. The present call specifically invites applications for the research focus of the University Cancer Center on `Epigenetics and non-coding-RNA in cancer gene regulation´. For detailed information on the research project, please visit our website:

(http://www.hhu.de/dso > Stipendienprogramme > PhD Stipendien)

The DSO interdisciplinary graduate training program in cancer research offers next to an outstanding collaborative research environment an excellent qualification program with practical training and transferable skills courses. In addition, individual mentoring and career development possibilities are offered.

We invite applications from highly qualified students with a background in the life sciences (biology, biochemistry, molecular medicine, pharmacy, etc.) and a strong interest in basic and translational cancer research. Applicants must hold a Master of Science, state examination or diploma degree. Scholarships are provided according to the standards of the DFG (German Research Foundation) and are available for up to three years. Funding will start in December 2014 / January 2015.
Applications should be submitted to:

Prof. Dr. Thomas Kurz
Thomas.kurz@hhu.de

(as one pdf-file) by 31.10.2014 containing:

1. Motivation letter
2. CV
3. Acquired techniques
4. References
5. Certificates and supplements (transcript of records)
 
 

Kontaktdaten


Art des Bewerbungszugangs
ONE pdf-file containing:

1. Motivation letter
2. CV
3. Acquired techniques
4. References
5. Certificates and supplements (transcript of records)

Application deadline: 31.10.2014
Kontakt für Bewerbungen
Prof. Dr. Thomas Kurz

Heinrich-Heine-Universität Düsseldorf
Institut für Pharmazeutische und Medizinische Chemie
Universitätsstraße 1 / Gebäude 26.23.
40225 Düsseldorf
 
 

Details der Stellenanzeige


Arbeitszeit
Vollzeit
Vertragslaufzeit
Befristete Anstellung
Stellentyp
Promotionsstelle
Berufserfahrung
Berufserfahrung nicht vorausgesetzt
Region
Deutschland (Nordrhein-Westfalen)
Arbeitsort
40225 Düsseldorf
Fachgebiet
Humanmedizin, Biologie & Life Sciences
JETZT BEWERBEN